CHUKWUDI OKAFOR: Open Payments
NPI 1184117970 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 8 payments from 6 companies in 2025. Trend: 2023 $83 · 2024 $0 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $35 |
| Lundbeck LLC | 1 | $31 |
| Alkermes, Inc. | 1 | $27 |
Products named: VRAYLAR, CAPLYTA, INVEGA SUSTENNA, REXULTI, LYBALVI, AUSTEDO XR, UZEDY.
Industry payments across VA — which companies pay providers there.
